Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncotarget|August 25, 2016
Sensitizing thermochemotherapy with a PARP1-inhibitorArlene L Oei, Lianne E M Vriend, Caspar M van Leeuwen, et al.
Frontiers in Oncology|April 3, 2023
Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer originRoxan F C P A Helderman, Bella Bokan, Gregor G W van Bochove, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 27, 2019
Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermiaAnirudh Sharma, Sanem Özayral, Julia S Caserto, et al.
International Journal of Radiation Oncology, Biology, Physics|October 11, 2023
Radiosensitization by Hyperthermia Critically Depends on the Time IntervalXionge Mei, H Petra Kok, Hans M Rodermond, et al.
Cells|July 30, 2020
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell LinesRoxan F C P A Helderman, Daan R Löke, Jan Verhoeff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2022
Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature mattersAkke Bakker, C Paola Tello Valverde, Geertjan van Tienhoven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2025
High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancerXionge Mei, Seth-Frerich Fobian, Marloes IJff, et al.
BMC Cancer|May 10, 2023
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocolYasmin A Civil, Arlene L Oei, Katya M Duvivier, et al.
Cell Reports. Medicine|April 26, 2024
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastasesSanne Bootsma, Mark P G Dings, Job Kesselaar, et al.
Pageof 5